Aflac (NYSE:AFL – Get Free Report) and AMERISAFE (NASDAQ:AMSF – Get Free Report) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Aflac and AMERISAFE, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Aflac | 2 | 9 | 3 | 0 | 2.07 |
AMERISAFE | 0 | 1 | 1 | 0 | 2.50 |
Aflac currently has a consensus target price of $106.50, indicating a potential upside of 1.85%. AMERISAFE has a consensus target price of $59.50, indicating a potential upside of 35.75%. Given AMERISAFE’s stronger consensus rating and higher possible upside, analysts plainly believe AMERISAFE is more favorable than Aflac.
Dividends
Valuation & Earnings
This table compares Aflac and AMERISAFE”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Aflac | $17.14 billion | 3.30 | $5.44 billion | $6.40 | 16.34 |
AMERISAFE | $309.04 million | 2.70 | $55.44 million | $2.48 | 17.67 |
Aflac has higher revenue and earnings than AMERISAFE. Aflac is trading at a lower price-to-earnings ratio than AMERISAFE, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Aflac and AMERISAFE’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Aflac | 21.27% | 15.55% | 3.30% |
AMERISAFE | 15.76% | 16.41% | 3.87% |
Risk and Volatility
Aflac has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, AMERISAFE has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.
Insider & Institutional Ownership
67.4% of Aflac shares are owned by institutional investors. Comparatively, 97.4% of AMERISAFE shares are owned by institutional investors. 0.9% of Aflac shares are owned by insiders. Comparatively, 1.6% of AMERISAFE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Aflac beats AMERISAFE on 9 of the 17 factors compared between the two stocks.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
About AMERISAFE
AMERISAFE, Inc., an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. AMERISAFE, Inc. was incorporated in 1985 and is based in DeRidder, Louisiana.
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.